May 9, 2002New England Journal of Medicine
Aspirin for Primary Prevention of Coronary Events
Key result
Aspirin for primary prevention of myocardial infarction is discussed in the context of a 45-year-old asymptomatic man with hyperlipidemia and a family history of premature heart disease.
Authors
Discussion
Loading...
Member takes
Implication
Aspirin may warrant individualized discussion in this profile; extends RCT data to shared decision-making for primary prevention.
Study Design
Type
Case Report (n=1)
PICO
P
Population
A 45-year-old asymptomatic man with a strong family history of premature heart disease and hyperlipidemia being evaluated for primary prevention with aspirin.
I
Intervention / Comparator
Aspirin
O
Primary Outcome
Risk of myocardial infarction
Cite This Study
Michael S. Lauer (2002) conducted a case report in Primary prevention of coronary events (n=1). Aspirin was evaluated on Risk of myocardial infarction. Aspirin for primary prevention of myocardial infarction is discussed in the context of a 45-year-old asymptomatic man with hyperlipidemia and a family history of premature heart disease.